Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination Patients With Thalassemic and Falcemic Syndromes
Clinical trial NCT05157256 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05157256
- Sponsor
- Società Italiana Talassemie ed Emoglobinopatie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-01
- Primary completion
- 2030-12-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.